Jennifer Lee1, Elizabeth E Eklund2, Geralyn Lambert-Messerlian1,2, Glenn E Palomaki1,2, Kristen Butterfield3, Patrizia Curran4, Ghada Bourjeily1,4,5. 1. 1 Department of Medicine, Warren Alpert Medical School of Brown University , Providence, Rhode Island. 2. 2 Department of Pathology and Laboratory Medicine, Women & Infants Hospital of Rhode Island , Providence, Rhode Island. 3. 3 Department of Clinical and Academic Quality Initiatives, Rhode Island Hospital , Providence, Rhode Island. 4. 4 Women's Medicine Collaborative, The Miriam Hospital , Providence, Rhode Island. 5. 5 Department of Medicine, The Miriam Hospital , Providence, Rhode Island.
Abstract
BACKGROUND: Pregnancy is a risk factor for sleep disordered breathing, including obstructive sleep apnea (OSA). Progesterone, one of the key hormones in pregnancy, a known respiratory drive stimulant, increases ventilation and may protect against OSA. We aimed to examine the relationship between circulating progesterone and OSA, after accounting for body weight and gestational age. METHODS: A case control study was conducted of pregnant women with OSA and those at low risk for the disorder. Cases were identified by ICD-9 code and review of medical record. Controls were identified if they scored zero (never) for snoring, apnea, and gasping on the multivariable apnea prediction index questionnaire immediately following delivery. Subjects with available stored first and/or second trimester residual serum samples were then included in this study and serum analyzed for progesterone. Raw progesterone levels were adjusted for the effects of gestational age and maternal weight. RESULTS: Twenty-seven cases and 64 controls with available serum were identified. Women with OSA had greater maternal weight and higher rates of related comorbidities, compared to controls. Progesterone levels correlated positively with gestational age and negatively with greater weight. Progesterone levels, adjusted for gestational age and maternal weight and expressed as multiples of median (MoM), were significantly lower in OSA cases compared to controls in both the first trimester (MoM = 0.71, confidence interval [95% CI] 0.60-0.83) relative to the MoM in controls of 1.00. In the second trimester levels were also lower in OSA cases (MoM = 0.84, 95% CI 0.73-0.96) compared to the MoM of 1.00 in controls. CONCLUSIONS: Progesterone levels, after accounting for weight and gestational age, were lower in women with OSA than controls. Progesterone may play a protective role against OSA.
BACKGROUND: Pregnancy is a risk factor for sleep disordered breathing, including obstructive sleep apnea (OSA). Progesterone, one of the key hormones in pregnancy, a known respiratory drive stimulant, increases ventilation and may protect against OSA. We aimed to examine the relationship between circulating progesterone and OSA, after accounting for body weight and gestational age. METHODS: A case control study was conducted of pregnant women with OSA and those at low risk for the disorder. Cases were identified by ICD-9 code and review of medical record. Controls were identified if they scored zero (never) for snoring, apnea, and gasping on the multivariable apnea prediction index questionnaire immediately following delivery. Subjects with available stored first and/or second trimester residual serum samples were then included in this study and serum analyzed for progesterone. Raw progesterone levels were adjusted for the effects of gestational age and maternal weight. RESULTS: Twenty-seven cases and 64 controls with available serum were identified. Women with OSA had greater maternal weight and higher rates of related comorbidities, compared to controls. Progesterone levels correlated positively with gestational age and negatively with greater weight. Progesterone levels, adjusted for gestational age and maternal weight and expressed as multiples of median (MoM), were significantly lower in OSA cases compared to controls in both the first trimester (MoM = 0.71, confidence interval [95% CI] 0.60-0.83) relative to the MoM in controls of 1.00. In the second trimester levels were also lower in OSA cases (MoM = 0.84, 95% CI 0.73-0.96) compared to the MoM of 1.00 in controls. CONCLUSIONS:Progesterone levels, after accounting for weight and gestational age, were lower in women with OSA than controls. Progesterone may play a protective role against OSA.
Authors: Stephen M Johnson; Karanbir S Randhawa; Jenna J Epstein; Ellen Gustafson; Austin D Hocker; Adrianne G Huxtable; Tracy L Baker; Jyoti J Watters Journal: Respir Physiol Neurobiol Date: 2017-11-22 Impact factor: 1.931
Authors: Erla S Sigurðardóttir; Thorarinn Gislason; Bryndis Benediktsdottir; Steinar Hustad; Payam Dadvand; Pascal Demoly; Karl A Franklin; Joachim Heinrich; Mathias Holm; Diana A van der Plaat; Rain Jõgi; Benedicte Leynaert; Eva Lindberg; Jesus Martinez-Moratalla; Leire Sainz De Aja; Giancarlo Pesce; Isabelle Pin; Chantal Raherison; Antonio Pereira-Vega; Francisco Gómez Real; Kai Triebner Journal: PLoS One Date: 2022-06-22 Impact factor: 3.752
Authors: Balachandran Kumarendran; Dana Sumilo; Michael W O'Reilly; Konstantinos A Toulis; Krishna M Gokhale; Chandrika N Wijeyaratne; Arri Coomarasamy; Wiebke Arlt; Abd A Tahrani; Krishnarajah Nirantharakumar Journal: Eur J Endocrinol Date: 2019-04 Impact factor: 6.664
Authors: Yasmin A Harrington; Jeanine M Parisi; Daisy Duan; Darlynn M Rojo-Wissar; Calliope Holingue; Adam P Spira Journal: Front Aging Neurosci Date: 2022-07-14 Impact factor: 5.702